Stay updated on UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Sign up to get notified when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.

Latest updates to the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference1%
- Check39 days agoChange DetectedDifference0.9%
- Check46 days agoChange DetectedThe page has undergone significant changes regarding the study of UCART123 for relapsed/refractory acute myeloid leukemia, with the removal of detailed study descriptions and inclusion/exclusion criteria, while a new version number has been added.SummaryDifference14%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.5%
Stay in the know with updates to UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.